Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan · Delayed Price · Currency is TWD 32.30
-0.70 (-2.12%)
Sep 8, 2026, 1:30 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 4.24 billion as of September 8, 2026. Its market cap has decreased by -30.46% in one year.
Market Cap
4.24B
Enterprise Value
3.64B
Revenue
53.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.30
ChartMarket Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has decreased from 4.86B to 4.24B, a decrease of -12.78%. That is a compound annual growth rate of -2.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 4.24B | -36.75% |
| Dec 31, 2025 | 6.70B | -1.89% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
| Feb 22, 2022 | 4.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mycenax Biotech | 4.96B |
| Medigen Biotechnology | 4.88B |
| UnicoCell Biomed | 4.69B |
| Great Novel Therapeutics Biotech & Medicals | 3.93B |
| Formosa Pharmaceuticals | 3.72B |
| Sinew Pharma | 3.69B |
| BioGend Therapeutics | 3.59B |
| SYN-TECH Chem. & Pharm. | 3.35B |